Evidence born from ASCOT trial – still important after 15 years
The paper presents the overview evolution of hypertension identification and treatment during last 15 years after publication of ASCOT trial (AngloScandinavian Cardiac Outcomes Trial) results. It discusses possible mechanism of more significant cardiovascular risk reduction in amlodipine/ perindopri...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2021-09-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/6282 |